Pseudovirus News and Research

RSS
Efficacy of mRNA vaccine-induced memory B cells against SARS-CoV-2 variants

Efficacy of mRNA vaccine-induced memory B cells against SARS-CoV-2 variants

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Researchers examine efficacy of CT-P59 monoclonal antibody against SARS-CoV-2 Brazil variant

Researchers examine efficacy of CT-P59 monoclonal antibody against SARS-CoV-2 Brazil variant

Neutralizing aptamers block SARS-CoV-2 infection in vitro

Neutralizing aptamers block SARS-CoV-2 infection in vitro

Durable antibody response at least 8 months following vaccination with J&J COVID vaccine

Durable antibody response at least 8 months following vaccination with J&J COVID vaccine

COVID-19 vaccination induces highly variable immunity among the immunocompromised

COVID-19 vaccination induces highly variable immunity among the immunocompromised

Moderna's COVID vaccine effective against emerging variants including Delta

Moderna's COVID vaccine effective against emerging variants including Delta

Is the SARS-CoV-2 delta variant threatening vaccine efficacy?

Is the SARS-CoV-2 delta variant threatening vaccine efficacy?

Cationic peptides inhibit SARS-CoV-2 cell entry

Cationic peptides inhibit SARS-CoV-2 cell entry

Oxford study sheds light on level of antibodies needed to protect against COVID-19 symptoms

Oxford study sheds light on level of antibodies needed to protect against COVID-19 symptoms

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Indian SARS-CoV-2 variant has unique infection and immune escape strategy say researchers

Indian SARS-CoV-2 variant has unique infection and immune escape strategy say researchers

Vaccinated individuals previously infected with SARS-CoV-2 show robust neutralization of the B.1.1.7 variant

Vaccinated individuals previously infected with SARS-CoV-2 show robust neutralization of the B.1.1.7 variant

Multivalent antibodies show high potency against SARS-CoV-2 in new study

Multivalent antibodies show high potency against SARS-CoV-2 in new study

Novel ferritin nanoparticle vaccine candidate effective against SARS-CoV-2 variants in preclinical trials

Novel ferritin nanoparticle vaccine candidate effective against SARS-CoV-2 variants in preclinical trials

Mouse-adapted SARS-CoV-2 and simian adenovirus vector advance COVID-19 vaccine research

Mouse-adapted SARS-CoV-2 and simian adenovirus vector advance COVID-19 vaccine research

Study observes increased breadth of SARS-CoV-2 antibody neutralization acquired over one year

Study observes increased breadth of SARS-CoV-2 antibody neutralization acquired over one year

RBD and NTD antibody cocktail could prevent the emergence of SARS-CoV-2 escape mutants

RBD and NTD antibody cocktail could prevent the emergence of SARS-CoV-2 escape mutants

Humoral innate pattern recognition molecules against SARS-CoV-2

Humoral innate pattern recognition molecules against SARS-CoV-2

New Astra-Zeneca B.1.351 vaccine AZD2816 strongly immunogenic against multiple SARS-CoV-2 variants of concern

New Astra-Zeneca B.1.351 vaccine AZD2816 strongly immunogenic against multiple SARS-CoV-2 variants of concern